Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Costs of theMRIdian on-table adaptive radiotherapy in comparison to conventional radiotherapy are not discussed. Given that it is new and more personalized than current treatment options it's likely to be correspondingly more expensive. Certainly, more frequent MRIs would be very costly. The release provides exact information about increased survival rates in the cohorts of individuals treated with the adaptive versus the convention radiotherapy techniques. "The cohort receiving a higher dose demonstrated a near doubling of median overall survival (Kaplan-Meier estimated median overall survival of 27.8 months compared to 14.8 months)." The news release provides specific results regarding experiences of both groups with regard to toxicity from radiotherapy. We appreciate that the headline of this release starts with the words "early data" because this report deals with preliminary and retrospective research. It was not a clinical trial. Instead, results are based on retrospectively comparing treatment of two groups of patients at four institutions. Respective comparisons can't account for a host of factors that might influence results. At the end of the news release readers are told that on the basis of these promising results a clinical trial is being planned. With five-year survival rates of 1 to 14%, it would be hard to engage in disease mongering about pancreatic cancer. This research was sponsored by ViewRay, the company that developed the MRIdian system, and the release does a good job calling attention to this. However, according to the published study, at least one of the co-authors received honoraria from ViewRay Medical Systems. Since this was not included in the release we're rating this criteria Not Satisfactory. This study was all about comparing alternatives, so it scores Satisfactory on that criterion. It would have helped readers if alternatives would have been described more in laymen's terms. The news release notes that the next step is a prospective clinical trial and that tells savvy readers that this treatment strategy has a long road of testing ahead. Still, we think the release could have done a better job clarifying that this therapy is not yet ready for patients, outside of the clinical trial. A study that suggests a doubling of median survival is sure to capture the attention of patients newly diagnosed with pancreatic cancer. These patients and their families are closely aware of the glum statistics for the disease. This is a practical concern that the release should have touched on. This technology is indeed novel and unique to ViewRay, though it is becoming available in more and more cancer treatment centers. No unjustifiable language was identified in the news release. Claim: Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer
[A]: This news release reports results of a retrospective study comparing conventional radiotherapy for inoperable pancreatic cancer versus an adaptive radiation therapy that allows clinicians to see the tumor in real time and respond to changes on a daily basis. Targeting the tumor more specifically means higher doses of radiation can be used without increasing damage to surrounding tissues. The study, funded by ViewRay, maker of the MRIdian system, is admittedly preliminary. It is to be followed up by a clinical trial. The release would have been more helpful to readers had it mentioned costs and disclosed a conflict of interest between one of the study authors and the device manufacturer. Surgery is an option only for certain less common types of pancreatic cancer. The five-year survival rates for pancreatic cancers that cannot be treated with surgery are 12% to 14% even for those diagnosed in stage I; the five-year survival rate for cancers detected at stage IV is about 1%, according to the American Cancer Society. ACS reminds readers that five-year survival rates are estimates and that "many people live longer often much longer than 5 years." In that context, a treatment that could extend the lives of the 1.5% of Americans who develop pancreatic cancer is big news.

[Q]: Paragraph: A nurse extracts a vaccine in a file photo. Federal health officials said on Thursday the government has not conceded that vaccines cause autism even after a Georgia girl won federal compensation in a case arguing a vaccine led to her brain damage. REUTERS/Phil Klein Hannah Poling, 9, had a rare mitochondrial disorder and a federal court ruling said regular childhood vaccinations may have contributed to some of her autism-like symptoms. She was awarded compensation under the National Vaccine Injury Compensation Program in a case that became public this week. Some activists who argue vaccines can trigger autism jumped on the case as vindication of their cause. But Dr. Julie Gerberding, director of the U.S. Centers for Disease Control and Prevention, denied this. "Let me be very clear that (the) government has made absolutely no statement about indicating that vaccines are a cause of autism," Gerberding told reporters in a telephone briefing. "That is a complete mischaracterization of the findings of the case, and a complete mischaracterization of any of the science that we have at our disposal today. So I think we need to set the record straight on that." The vaccine injury program is a no-fault system that has a $2.5 billion fund built up from a 75-cent-per-dose tax on vaccines. It was set up to ensure companies would not be afraid to make vaccines, and to provide injured children an easier way to seek compensation. Thousands of lawsuits have been filed by parents who argue their children have autism caused by vaccines. The Institute of Medicine, an independent organization set up to inform U.S. policy, has found there is no evidence that vaccines can cause autism. Many recent studies have come to the same conclusion. Some autism advocacy groups argue that a mercury-containing preservative in vaccines called thimerosal can cause autism. Republican presidential candidate Sen. John McCain entered the debate last week, saying there is "strong evidence" linking autism to a thimerosal. Dr. Edwin Trevathan, director of the CDC's National Center on Birth Defects and Developmental Disabilities, said the Poling case did not demonstrate any link between vaccines and autism. "I think it's also worth noting that most children with autism do not seem to have a mitochondrial problem," he told the briefing. "So this association between mitochondrial disorders and autism is actually probably relatively rare. But the association between mitochondrial disorders and severe brain damage and dysfunction is one that is not as rare and is actually quite important." Trevathan said it is not clear whether a fever caused by a vaccine might further stress a child with such a condition, causing autism-like symptoms. Autism can have relatively mild symptoms or can severely disable a child by interfering with speech and behavior. No one knows what causes it. The CDC estimates that about one in every 150 children has autism or a related disorder such as Asperger's syndrome 560,000 people up to age 21 in the United States. "Our message to parents is that immunization is life-saving. There's absolutely nothing changed in the adamant recommendations that we are making to get children vaccinated," Gerberding said. Claim: Still no autism-vaccine link, say health officials.
[A]: Federal health officials said on Thursday the government has not conceded that vaccines cause autism even after a Georgia girl won federal compensation in a case arguing a vaccine led to her brain damage.

[Q]: Paragraph: The Kearney Hub reports that Mayor Stan Clouse made the request at Tuesday's City Council meeting. He mentioned Grand Island's ban on vaping in public places and Kearney Public Schools barring vaping devices from school property. He told the Kearney Hub after the meeting that he's not a fan of "too much government," but said: "If the schools are worried about vaping, maybe we should be too." Public health experts have been trying to determine what's causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes. The ailment has sickened at least 530 people and killed nine. ___ Information from: Kearney Hub, http://www.kearneyhub.com/ Claim: Kearney to study ban on vaping in public places.
[A]:
Kearney's mayor has asked city staffers to study whether vaping is a threat to public health and should be banned from public places in the city.